PROTYzer

POCT Analyzer (ProMax-150)

PROTYzer Medical System

Type/Category: POCT Analyzer

Test speed

POCT Analyzer (ProMax-150)

Description

The POCT Immunofluorescence Quantitative Analyzer is used cooperatively with special fluor immunoassay reagent strips and applicable to fluor immunoassay of human body samples. The product can be used for semiquantitative and quantitative immunoassay of medical, ant epidemic and scientific research institutions.

Features

Ultra-high Sensitivity and excellent precision.
Fast and Flexible, result in short time.
Intelligent QR code management.
Real-time data transmission, compatible with LIS/HIS.
Store 10,000 results.
Large touch screen LCD display.

Specifications

Model	ProMax-10
Test Item	The product is used cooperatively with immunofluorescence assay kit produced by our company.
Excitation Light Source	LED
Wavelength Range	740nm
Test Item Parameter	The user can read configuration parameters of the instrument from information card.
Sample Type	Whole blood, serum, plasma, urine and faeces (subject to specification of immunofluorescence assay kit)
Delay Test	Delay test time can be set. Place test card in the instrument and test at fixed time after completion of reaction
Test Speed	240 times/hour
Background Number	Fluorescence value should be ≤5
Repeatability	The variable coefficient of fluorescence value of fluorescence test cards of different intensities repeatedly measured by the instrument CV≤2.0%
Stability	The relative deviation between the test result at 4th hour and the 8th hour after the instrument is working stably and the test result when the instrument just works stably is limited to ±3.0%.
Accuracy	When the instrument tests the calibrated fluorescence test card, the deviation between the measured fluorescence value and the calibration value of the fluorescence test card is ±3.0%.
Measuring Time	The time from inserting the fluorescence test card to displaying the test result should not exceed 15s.
Linearity Range	Within the concentration range of standards no less than two orders of magnitudes, the linearly dependent coefficient of the fluorescence value and concentration read by the instrument r≥0.990
Electricity	AC 100V-240V 50Hz/60Hz; Host: DC12V 5A
Input Power	60 VA
Dimension	200300140mm
Net Weight	2.0kg

Menu of assays

Biomarkers	Product Item	Specimen	Reaction Time	Measuring Range	Clinical Range	Intended Use
Cardiac	cTnl	WB/Serum/Plasma	12min.	0.1-40ng/mL	<0.3ng/mL	Several heart diseases including myocardial infarction and heart failure.
	Myo	WB/Serum/Plasma	12min.	5-400ng/mL	<58ng/mL	Acute myocardial infarction (AMI) in early stage.
	CK-MB	WB/Serum/Plasma	12min.	1-200ng/mL	<5ng/mL	Acute myocardial infarction (AMI) in early stage.
	NT-proBNP	WB/Serum/Plasma	10min.	20-35000pg/mL	Under75:0~347pg/mL Over75:0~449pg/mL	Heart failure.
	D-Dimer	WB/Plasma	10min.	40-10000ng/mL	<500ng/mL	Disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction,etc.
	cTnl+Myo+ CKMB	WB/Serum/Plasma	12min.	Same with single item	Same with single item	Triple marker of myocardial infarction.
	ST2	WB/Serum/Plasma	10min.	10-400ng/mL	<35ng/mL	Heart failure.
	Lp-PLA2	WB/Serum/Plasma	10min.	10-900ng/mL	<175ng/mL	Risk evaluation of ACS and atherosclerotic ischemic stroke patients.
	H-FABP	WB/Serum/Plasma	10min.	2.5-160ng/mL	<5ng/mL	Acute myocardial infarction (AMl) in early stage.
	HCY	WB/Serum/Plasma	15min.	1-50μmol/L	5-15μmol/L	Atherosclerosis, venous embolism, coronary heart disease.
Inflammation	CRP/hs-CRP	WB/Serum/Plasma	3min.	0.5-200mg/L	CRP<10mg/L hs-CRP<1mg/L	Nonspecficity inflammatory marker.
	SAA	WB/Serum	5min.	1-200mg/L	<10mg/L	Inflammation &infection.
	PCT	WB/Serum/Plasma	10min.	0.2-100ng/mL	<0.5ng/mL	Sepsis.
	CRP+SAA	WB/Serum/Plasma	5min.	Same with single item	Same with single item	Inflammation &infection.
	IL-6	WB/Serum/Plasma	10min.	5-4000pg/mL	10pg/mL	Diabetes, rheumatoid arthritis,etc.
	Calprotectin	Fecal specimens	10min.	5-1000mg/g	<50mg/g	Enteritis.
Thyroid Hormone	TSH	WB/Serum/Plasma	15min.	0.3-100mU/L	0.3-4.2mU/L	Hyperthyroidism and hypothyroidism.
	T3	WB/Serum/Plasma	15min.	0.5-10nmol/L	1.23-3.07nmol/L	Thyroid dysfunction.
	Tπ4	WB/Serum/Plasma	15min.	5-300nmol/L	66-181nmol/L	Thyroid dysfunction.
	FT3	WB/Serum/Plasma	15min.	1-50pmol/L	3.1-6.8pmol/L	Thyroid dysfunction.
	FT4	WB/Serum/Plasma	15min.	5-100pmol/L	12-22pmol/L	Thyroid dysfunction.
Tumor Maker	AFP	WB/Serum/Plasma	10min.	2.5-200ng/mL	<20ng/mL	Pregnancy cancer.
	CEA	WB/Serum/Plasma	10min.	1-200ng/mL	<5ng/mL	Colon cancer, colorectal cancer,etc.
	NSE	WB/Serum/Plasma	10min.	1-400ng/mL	<16ng/mL	Non-small cell lung cancer.
	FOB	Fecal specimens	10min.	50-1000ng/mL	<100ng/mL	Abnormal recessive gastrointestinal bleeding.
	PGIⅡI	WB/Serum/Plasma	10min.	1-100ug/L	PGI/PGII>3.0	Gastric abnormalities.
	PGI	WB/Serum/Plasma	10min.	2.5-200ug/L	>70ng/mL	Gastric abnormalities.
	TPSA	WB/Serum/Plasma	10min.	0.5-40ng/mL	<4ng/mL	Prostate cancer.
	FPSA	WB/Serum/Plasma	10min.	0.1-10ng/mL	<1ng/mL	Prostate cancer.
	CA12-5	WB/Serum/Plasma	10min.	20-500U/mL	<35U/mL	Ovarian cancer.
	CA15-3	WB/Serum/Plasma	10min.	10-400U/mL	<25U/mL	Breast cancer.
	HE4	WB/Serum/Plasma	10min.	50-2000pmol/L	<140pmol/L	Ovarian cancer.
	CA19-9	WB/Serum/Plasma	10min.	10-400U/mL	<27U/mL	Pancreatic cancer.
	HCG	WB/Serum/Plasma	10min.	5-400mIU/mL	<10mIU/mL	Early pregnancy, ectopic HCG cancer, incomplete abortion.
	CK19 (Cyfra21-1)	WB/Serum/Plasma	10min.	1-100ng/mL	<3.3ng/mL	Non-small cell lung cancer.